Royce & Associates’s Magellan Health Services, Inc. MGLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-8,265
Closed -$779K 1035
2021
Q2
$779K Sell
8,265
-1,859
-18% -$175K 0.01% 874
2021
Q1
$944K Sell
10,124
-6,856
-40% -$642K 0.01% 860
2020
Q4
$1.41M Hold
16,980
0.01% 778
2020
Q3
$1.29M Sell
16,980
-916
-5% -$68K 0.01% 750
2020
Q2
$1.31M Sell
17,896
-119
-0.7% -$7.62K 0.01% 736
2020
Q1
$867K Buy
18,015
+4,515
+33% +$290K 0.01% 757
2019
Q4
$1.06M Buy
13,500
+6,705
+99% +$472K 0.01% 804
2019
Q3
$422K Buy
+6,795
New +$453K ﹤0.01% 914
2014
Q4
Sell
-9,662
Closed -$529K 1408
2014
Q3
$529K Sell
9,662
-393,744
-98% -$22.6M ﹤0.01% 1207
2014
Q2
$25.1M Sell
403,406
-756,242
-65% -$44.4M 0.07% 329
2014
Q1
$68.8M Hold
1,159,648
0.2% 133
2013
Q4
$69.5M Sell
1,159,648
-140,768
-11% -$8.4M 0.2% 133
2013
Q3
$78M Buy
1,300,416
+3,630
+0.3% +$210K 0.23% 115
2013
Q2
$72.7M Buy
+1,296,786
New +$67.9M 0.22% 117

Other funds holding MGLN

Royce & Associates's MGLN Position: Q3 2021 in Review

Royce & Associates sold out of Magellan Health Services, Inc. (MGLN) in Q3 2021, closing a stake of 8,265 shares — an estimated $779K sold.

Royce & Associates first reported a position in MGLN in Q2 2013 and held it in 14 quarters. The position peaked at $78M in Q3 2013. 178 funds tracked by Wall St. Rank hold MGLN as of Q3 2021.

  • Royce & Associates reported no remaining Magellan Health Services, Inc. position as of Q3 2021 after selling out during the quarter.
  • Royce & Associates sold 8,265 Magellan Health Services, Inc. shares in Q3 2021, an estimated $779K.
  • Royce & Associates first reported a position in Magellan Health Services, Inc. in Q2 2013 and held it in 14 quarters.
  • Royce & Associates's Magellan Health Services, Inc. position peaked at $78M in Q3 2013.
  • 178 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q3 2021.

Based on Royce & Associates's 13F filing for Q3 2021, filed 10 Nov 2021.